Acorda Therapeutics to Present at Baird and Stifel Nicolaus 2012 Healthcare Conferences

Posted: Published on August 29th, 2012

This post was added by Dr Simmons

ARDSLEY, N.Y.--(BUSINESS WIRE)--

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will present at two upcoming conferences in September.

Jane Wasman, Chief, Strategic Development and General Counsel, will present at the Baird 2012 Health Care Conference on Wednesday, September 5, 2012 at 8:25 am ET at the New York Palace Hotel in New York. A live audio webcast of the presentation can be accessed under Investor Events in the Investor section of the Acorda website at http://www.acorda.com, or you may use the link:

http://wsw.com/webcast/baird30/acor/

Ron Cohen, Acordas President and Chief Executive Officer will present at the Stifel Nicolaus 2012 Healthcare Conference on Thursday, September 6, 2012 at 4:25 pm ET at the Four Seasons Hotel in Boston. A live audio webcast of the presentation can be accessed under Investor Events in the Investor section of the Acorda website at http://www.acorda.com, or you may use the link:

http://www.veracast.com/webcasts/stifel/healthcare2012/29215201.cfm

Archived versions of these webcasts will be available until October 5, 2012 on the Investors section of http://www.acorda.com.

About Acorda Therapeutics

Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with MS, spinal cord injury and other neurological conditions.

Acorda markets AMPYRA (dalfampridine) Extended Release Tablets, 10 mg, in the United States as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an improvement in walking speed. AMPYRA is marketed outside the United States as FAMPYRA (prolonged-release fampridine tablets) by Biogen Idec under a licensing agreement from Acorda. AMPYRA and FAMPYRA are manufactured under license from Alkermes Pharma Ireland Limited.

Original post:
Acorda Therapeutics to Present at Baird and Stifel Nicolaus 2012 Healthcare Conferences

Related Posts
This entry was posted in Spinal Cord Injury Treatment. Bookmark the permalink.

Comments are closed.